The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Real-time identification of tumor lesions and response to vintafolide treatment.
Wael A. Harb
Research Funding - Horizon Oncology Research
Siu-Long Yao
Employment or Leadership Position - Merck
Stock Ownership - Merck
Binh Nguyen
Employment or Leadership Position - Endocyte
Stock Ownership - Endocyte
Robin Mogg
Employment or Leadership Position - Merck
Stock Ownership - Merck